New Two-Pronged chemo attack on deadly pancreatic cancer
NCT ID NCT07030283
Summary
This early-stage trial is testing whether combining two chemotherapy approaches—one delivered directly into the abdomen and another into the bloodstream—is safe and effective for adults with pancreatic cancer that has spread to the abdominal lining. Researchers want to see if this combination can better control the cancer, potentially allowing some participants to later become eligible for surgery. The study will monitor side effects, cancer response, and survival in a small group of 10 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Colorado Cancer Center
RECRUITINGAurora, Colorado, 80045, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.